Safety for Success
Ensuring safety norms are followed in laboratories is one of the crucial criteria for pharmaceutical companies to bag a Good…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘Our strategy is to develop vaccines with better protection at lower cost’
With the rotavirus and cholera vaccines programmes reaching an important milestone by this year end, Dr Davinder Gill, Chief…
Suven Life Sciences secures product patents
Patents from Australia and Eurasia correspond to the NCEs for the treatment of disorders associated with neurodegene-rative…
DCG(I) plans IT-enabled system for fast CT approvals
Seeks stakeholders' suggestions/comments within three weeks
Cipla partners with BioQuiddity
Cipla Europe (Cipla) and BioQuiddity have entered into a commercial collaboration, covering the territory of the European Union…
Pharmexcil to celebrate 10th annual meet with host of events
Minister of Commerce, Government of India, senior officials from Department of Commerce, Pharmaceuticals, Health, DCG(I), Science…
GVK BIO launches brand CLINOGENT
To offer bioequivalence studies for generic pharma and late phase patient-based clinical studies for research-based companies
Glenmark plans facility in the US
The facility will manufacture oral solids, injectables and topicals
Expansion into new geographical markets drives M&A activity in pharma sector
M&A Activity in the pharmaceutical sector was focused on geographical expansion to create additional growth opportunities